Elsevier,
Current Developments in Nutrition, Volume 7, June 2023
The community-based MLMC intervention described in this paper had significant impacts on individual intake of dietary fat and carbohydrates. These dietary behaviors are important key factors related to chronic disease risk and further implementation of MLMC interventions could go someway way to improve dietary intake among Native American populations post-colonization.
Elsevier,
Australian and New Zealand Journal of Public Health, Volume 47, June 2023
This article highlights that although Indigenous research governance is recognised as an essential part of ethical Aboriginal and Torres Strait Islander research, activities and contributions made by Indigenous reference group (IRG) members are underreported.
Elsevier,
The Lancet Global Health, Volume 11, June 2023
This Article supports SDG 3 by presenting a conceptual framework and a method to estimate cost-effectiveness thresholds for 174 countries, using public and widely available data on country-specific health expenditures and health outcomes; these findings can inform policy makers on the thresholds to consider when deciding on the allocation of health resources.
Elsevier,
The Lancet Gastroenterology and Hepatology, Volume 8, June 2023
This Article supports SDG 3 by assessing the incidence of HIV and HCV infection among people who inject drugs, a population at higher risk of these infections. In this systematic review, HCV estimates came from studies in 24 countries. Pooled HCV incidence was 12.1 per 100 person-years; data for both infections were scarce, suggesting increased efforts are needed to keep track of these infections in this population.
Lancet Regional Health - Americas, Volume 22, June 2023
This Article supports SDG 3 by using modelling to estimate the impact of immigration on hepatitis B prevalence in the USA, in order to more accurately assess the hepatitis B burden, which might not be accurately measured by national serosurveys. The study found a significantly higher burden of hepatitis B (1.8 million cases), significantly higher than that found in national serosurveys.
Elsevier,
Lancet Regional Health - Americas, Volume 22, June 2023
This Article supports SDG 3 by showing that an HCV testing (point-of-care) and treatment programme implemented in users of a supervised drug cosumption service in Canada was beneficial, with a large degree of positive testing, testing acceptance, and treatment engagement. The study suggests that on-site point of care testing and treatment for HCV in supervised consumption services is effective in reaching this population
